Concourse Financial Group Securities, Inc. Amarin Corp Plcuk Transaction History
Concourse Financial Group Securities, Inc.
- $1.67 Billion
- Q4 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 8,000 shares of AMRN stock, worth $4,880. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,000
Previous 8,000
-0.0%
Holding current value
$4,880
Previous $5,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AMRN
# of Institutions
181Shares Held
68.6MCall Options Held
192KPut Options Held
78.1K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$15.2 Million3.7% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$7.57 Million0.38% of portfolio
-
Morgan Stanley New York, NY4.41MShares$2.69 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.53 Million1.0% of portfolio
-
Waterfront Wealth Inc.2.48MShares$1.51 Million0.31% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $246M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...